0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Drug Monitoring Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-18B12968
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Therapeutic Drug Monitoring Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Drug Monitoring Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-18B12968
Report
July 2025
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Therapeutic Drug Monitoring Market Size

In 2024, the global market size of Therapeutic Drug Monitoring was estimated to be worth US$ 2145 million and is forecast to reach approximately US$ 3841 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.

Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market

Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs. Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
The Therapeutic Drug Monitoring (TDM) market is growing due to an increasing focus on personalized medicine, which tailors treatments to the individual characteristics of each patient. TDM enables clinicians to optimize drug dosages for better efficacy and reduced toxicity, particularly important for drugs with narrow therapeutic windows, such as immunosuppressants, anti-epileptics, and certain antibiotics. As the incidence of chronic diseases rises globally, there is greater demand for precise dosing in treatments, which supports TDM's expanding role. Additionally, technological advancements in laboratory automation and assay sensitivity are making TDM more accessible and accurate, further driving market growth.
A significant challenge in the TDM market is the high cost of testing and the need for specialized equipment and expertise, which can limit its accessibility, especially in lower-income regions. TDM requires sophisticated instruments and skilled personnel to interpret results accurately, leading to a barrier for healthcare facilities without sufficient resources. Furthermore, in some cases, there is a lack of standardized protocols for monitoring certain drugs, creating inconsistencies in practices across healthcare systems. These factors may hinder the widespread adoption of TDM, especially in resource-constrained settings.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45%.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.
The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Therapeutic Drug Monitoring Market Report

Report Metric Details
Report Name Therapeutic Drug Monitoring Market
CAGR 8.8%
Segment by Type
  • Blood Test
  • Urine Test
  • Saliva Test
Segment by Application
  • Hospital Labs
  • Independent Clinical Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, Bühlmann Laboratories, Randox Laboratories, Sekisui Medical, DAT Diagnostic, Chromai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Therapeutic Drug Monitoring in global and regional level.
  • Chapter 3: Detailed analysis of Therapeutic Drug Monitoring company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Drug Monitoring revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

Who are the main players in the Therapeutic Drug Monitoring Market report?

Ans: The main players in the Therapeutic Drug Monitoring Market are Roche, Danaher, Abbott, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, bioMerieux, Bühlmann Laboratories, Randox Laboratories, Sekisui Medical, DAT Diagnostic, Chromai

What are the Application segmentation covered in the Therapeutic Drug Monitoring Market report?

Ans: The Applications covered in the Therapeutic Drug Monitoring Market report are Hospital Labs, Independent Clinical Laboratories, Others

What are the Type segmentation covered in the Therapeutic Drug Monitoring Market report?

Ans: The Types covered in the Therapeutic Drug Monitoring Market report are Blood Test, Urine Test, Saliva Test

1 Study Coverage
1.1 Therapeutic Drug Monitoring Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital Labs
1.3.3 Independent Clinical Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Therapeutic Drug Monitoring Market Size Estimates and Forecasts
2.2 Therapeutic Drug Monitoring Market Size by Region: 2024 Versus 2031
2.2.1 Global Therapeutic Drug Monitoring Revenue by Region: 2020-2025
2.2.2 Global Therapeutic Drug Monitoring Revenue Forecast by Region (2026-2031)
2.2.3 Global Therapeutic Drug Monitoring Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Therapeutic Drug Monitoring Revenue by Type (2020-2031)
3.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Therapeutic Drug Monitoring Revenue by Application (2020-2031)
3.2.2 Global Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Blood Test of Therapeutic Drug Monitoring Revenue Market Share by Application
3.3.2 Urine Test of Therapeutic Drug Monitoring Revenue Market Share by Application
3.3.3 Saliva Test of Therapeutic Drug Monitoring Revenue Market Share by Application
4 Global Therapeutic Drug Monitoring by Company
4.1 Global Therapeutic Drug Monitoring Revenue by Company (2020-2025)
4.2 Global Therapeutic Drug Monitoring Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Therapeutic Drug Monitoring Companies around the World: Ranking by Revenue
4.3.2 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Therapeutic Drug Monitoring Companies Headquarters & Product Type
4.4.1 Global Therapeutic Drug Monitoring Companies Headquarters
4.4.2 Date of International Companies Enter into Therapeutic Drug Monitoring Market
4.4.3 Global Therapeutic Drug Monitoring Companies Product & Service
4.4.4 Blood Test Revenue Market Share of Therapeutic Drug Monitoring by Company
4.4.5 Urine Test Revenue Market Share of Therapeutic Drug Monitoring by Company
4.4.6 Saliva Test Revenue Market Share of Therapeutic Drug Monitoring by Company
4.5 Global Therapeutic Drug Monitoring Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Roche
5.1.1 Roche Corporation Information
5.1.2 Roche Description, Business Overview
5.1.3 Roche Therapeutic Drug Monitoring Products Offered
5.1.4 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.1.5 Roche Therapeutic Drug Monitoring Revenue by Product in 2024
5.1.6 Roche Therapeutic Drug Monitoring Revenue by Application in 2024
5.1.7 Roche Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.1.8 Roche Recent Developments
5.2 Danaher
5.2.1 Danaher Corporation Information
5.2.2 Danaher Description, Business Overview
5.2.3 Danaher Therapeutic Drug Monitoring Products Offered
5.2.4 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.2.5 Danaher Therapeutic Drug Monitoring Revenue by Product in 2024
5.2.6 Danaher Therapeutic Drug Monitoring Revenue by Application in 2024
5.2.7 Danaher Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.2.8 Danaher Recent Developments
5.3 Abbott
5.3.1 Abbott Corporation Information
5.3.2 Abbott Description, Business Overview
5.3.3 Abbott Therapeutic Drug Monitoring Products Offered
5.3.4 Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.3.5 Abbott Therapeutic Drug Monitoring Revenue by Product in 2024
5.3.6 Abbott Therapeutic Drug Monitoring Revenue by Application in 2024
5.3.7 Abbott Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.3.8 Abbott Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Corporation Information
5.4.2 Thermo Fisher Scientific Description, Business Overview
5.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Products Offered
5.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.4.5 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue by Product in 2024
5.4.6 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue by Application in 2024
5.4.7 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.4.8 Thermo Fisher Scientific Recent Developments
5.5 Siemens Healthineers
5.5.1 Siemens Healthineers Corporation Information
5.5.2 Siemens Healthineers Description, Business Overview
5.5.3 Siemens Healthineers Therapeutic Drug Monitoring Products Offered
5.5.4 Siemens Healthineers Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.5.5 Siemens Healthineers Therapeutic Drug Monitoring Revenue by Product in 2024
5.5.6 Siemens Healthineers Therapeutic Drug Monitoring Revenue by Application in 2024
5.5.7 Siemens Healthineers Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.5.8 Siemens Healthineers Recent Developments
5.6 Bio-Rad Laboratories
5.6.1 Bio-Rad Laboratories Corporation Information
5.6.2 Bio-Rad Laboratories Description, Business Overview
5.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Products Offered
5.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.6.5 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue by Product in 2024
5.6.6 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue by Application in 2024
5.6.7 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.6.8 Bio-Rad Laboratories Recent Developments
5.7 bioMerieux
5.7.1 bioMerieux Corporation Information
5.7.2 bioMerieux Description, Business Overview
5.7.3 bioMerieux Therapeutic Drug Monitoring Products Offered
5.7.4 bioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.7.5 bioMerieux Therapeutic Drug Monitoring Revenue by Product in 2024
5.7.6 bioMerieux Therapeutic Drug Monitoring Revenue by Application in 2024
5.7.7 bioMerieux Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.7.8 bioMerieux Recent Developments
5.8 Bühlmann Laboratories
5.8.1 Bühlmann Laboratories Corporation Information
5.8.2 Bühlmann Laboratories Description, Business Overview
5.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring Products Offered
5.8.4 Bühlmann Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.8.5 Bühlmann Laboratories Therapeutic Drug Monitoring Revenue by Product in 2024
5.8.6 Bühlmann Laboratories Therapeutic Drug Monitoring Revenue by Application in 2024
5.8.7 Bühlmann Laboratories Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.8.8 Bühlmann Laboratories Recent Developments
5.9 Randox Laboratories
5.9.1 Randox Laboratories Corporation Information
5.9.2 Randox Laboratories Description, Business Overview
5.9.3 Randox Laboratories Therapeutic Drug Monitoring Products Offered
5.9.4 Randox Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.9.5 Randox Laboratories Therapeutic Drug Monitoring Revenue by Product in 2024
5.9.6 Randox Laboratories Therapeutic Drug Monitoring Revenue by Application in 2024
5.9.7 Randox Laboratories Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.9.8 Randox Laboratories Recent Developments
5.10 Sekisui Medical
5.10.1 Sekisui Medical Corporation Information
5.10.2 Sekisui Medical Description, Business Overview
5.10.3 Sekisui Medical Therapeutic Drug Monitoring Products Offered
5.10.4 Sekisui Medical Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.10.5 Sekisui Medical Therapeutic Drug Monitoring Revenue by Product in 2024
5.10.6 Sekisui Medical Therapeutic Drug Monitoring Revenue by Application in 2024
5.10.7 Sekisui Medical Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.10.8 Sekisui Medical Recent Developments
5.11 DAT Diagnostic
5.11.1 DAT Diagnostic Corporation Information
5.11.2 DAT Diagnostic Description, Business Overview
5.11.3 DAT Diagnostic Therapeutic Drug Monitoring Products Offered
5.11.4 DAT Diagnostic Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.11.5 DAT Diagnostic Therapeutic Drug Monitoring Revenue by Product in 2024
5.11.6 DAT Diagnostic Therapeutic Drug Monitoring Revenue by Application in 2024
5.11.7 DAT Diagnostic Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.11.8 DAT Diagnostic Recent Developments
5.12 Chromai
5.12.1 Chromai Corporation Information
5.12.2 Chromai Description, Business Overview
5.12.3 Chromai Therapeutic Drug Monitoring Products Offered
5.12.4 Chromai Therapeutic Drug Monitoring Revenue and Gross Margin (2020-2025)
5.12.5 Chromai Therapeutic Drug Monitoring Revenue by Product in 2024
5.12.6 Chromai Therapeutic Drug Monitoring Revenue by Application in 2024
5.12.7 Chromai Therapeutic Drug Monitoring Revenue by Geographic Area in 2024
5.12.8 Chromai Recent Developments
6 North America
6.1 North America Therapeutic Drug Monitoring Market Size YoY Growth 2020-2031
6.2 North America Therapeutic Drug Monitoring Market Facts & Figures by Country (2020-2031)
6.3 North America Therapeutic Drug Monitoring Revenue by Type (2020-2025)
6.4 North America Therapeutic Drug Monitoring Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Therapeutic Drug Monitoring Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Therapeutic Drug Monitoring Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Therapeutic Drug Monitoring Revenue by Type (2020-2025)
7.4 Asia-Pacific Therapeutic Drug Monitoring Revenue by Application (2020-2025)
8 Europe
8.1 Europe Therapeutic Drug Monitoring Market Size YoY Growth 2020-2031
8.2 Europe Therapeutic Drug Monitoring Market Facts & Figures by Country (2020-2031)
8.3 Europe Therapeutic Drug Monitoring Revenue by Type (2020-2025)
8.4 Europe Therapeutic Drug Monitoring Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring Market Size YoY Growth 2020-2031
9.2 Latin America Therapeutic Drug Monitoring Market Facts & Figures by Country (2020-2031)
9.3 Latin America Therapeutic Drug Monitoring Revenue by Type (2020-2025)
9.4 Latin America Therapeutic Drug Monitoring Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Therapeutic Drug Monitoring Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Therapeutic Drug Monitoring Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Therapeutic Drug Monitoring Revenue by Type (2020-2025)
10.4 Middle East and Africa Therapeutic Drug Monitoring Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Therapeutic Drug Monitoring Supply Chain Analysis
11.2 Therapeutic Drug Monitoring Key Raw Materials and Upstream Suppliers
11.3 Therapeutic Drug Monitoring Clients Analysis
11.4 Therapeutic Drug Monitoring Sales Channel and Sales Model Analysis
11.4.1 Therapeutic Drug Monitoring Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Therapeutic Drug Monitoring Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Therapeutic Drug Monitoring Distributors
12 Therapeutic Drug Monitoring Market Dynamics
12.1 Therapeutic Drug Monitoring Industry Trends
12.2 Therapeutic Drug Monitoring Market Drivers
12.3 Therapeutic Drug Monitoring Market Challenges
12.4 Therapeutic Drug Monitoring Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Therapeutic Drug Monitoring Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Therapeutic Drug Monitoring Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Therapeutic Drug Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Therapeutic Drug Monitoring Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Therapeutic Drug Monitoring Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Therapeutic Drug Monitoring Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Therapeutic Drug Monitoring Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Therapeutic Drug Monitoring Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Therapeutic Drug Monitoring Players by Revenue (US$ Million) in 2024
 Table 13. Global Therapeutic Drug Monitoring Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring as of 2024)
 Table 15. Global Therapeutic Drug Monitoring Companies Headquarters
 Table 16. Date of International Companies Enter into Therapeutic Drug Monitoring Market
 Table 17. Global Therapeutic Drug Monitoring Companies Product & Service
 Table 18. Global Therapeutic Drug Monitoring Mergers & Acquisitions, Expansion Plans
 Table 19. Roche Corporation Information
 Table 20. Roche Description and Business Overview
 Table 21. Roche Therapeutic Drug Monitoring Product
 Table 22. Roche Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Roche Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 24. Roche Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 25. Roche Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 26. Roche Recent Developments
 Table 27. Danaher Corporation Information
 Table 28. Danaher Description and Business Overview
 Table 29. Danaher Therapeutic Drug Monitoring Product
 Table 30. Danaher Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 32. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 33. Danaher Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 34. Danaher Recent Developments
 Table 35. Abbott Corporation Information
 Table 36. Abbott Description and Business Overview
 Table 37. Abbott Therapeutic Drug Monitoring Product
 Table 38. Abbott Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 40. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 41. Abbott Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 42. Abbott Recent Developments
 Table 43. Thermo Fisher Scientific Corporation Information
 Table 44. Thermo Fisher Scientific Description and Business Overview
 Table 45. Thermo Fisher Scientific Therapeutic Drug Monitoring Product
 Table 46. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 48. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 49. Thermo Fisher Scientific Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 50. Thermo Fisher Scientific Recent Developments
 Table 51. Siemens Healthineers Corporation Information
 Table 52. Siemens Healthineers Description and Business Overview
 Table 53. Siemens Healthineers Therapeutic Drug Monitoring Product
 Table 54. Siemens Healthineers Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 56. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 57. Siemens Healthineers Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 58. Siemens Healthineers Recent Developments
 Table 59. Bio-Rad Laboratories Corporation Information
 Table 60. Bio-Rad Laboratories Description and Business Overview
 Table 61. Bio-Rad Laboratories Therapeutic Drug Monitoring Product
 Table 62. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 64. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 65. Bio-Rad Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 66. Bio-Rad Laboratories Recent Developments
 Table 67. bioMerieux Corporation Information
 Table 68. bioMerieux Description and Business Overview
 Table 69. bioMerieux Therapeutic Drug Monitoring Product
 Table 70. bioMerieux Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 72. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 73. bioMerieux Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 74. bioMerieux Recent Developments
 Table 75. Bühlmann Laboratories Corporation Information
 Table 76. Bühlmann Laboratories Description and Business Overview
 Table 77. Bühlmann Laboratories Therapeutic Drug Monitoring Product
 Table 78. Bühlmann Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 80. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 81. Bühlmann Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 82. Bühlmann Laboratories Recent Developments
 Table 83. Randox Laboratories Corporation Information
 Table 84. Randox Laboratories Description and Business Overview
 Table 85. Randox Laboratories Therapeutic Drug Monitoring Product
 Table 86. Randox Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 88. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 89. Randox Laboratories Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 90. Randox Laboratories Recent Developments
 Table 91. Sekisui Medical Corporation Information
 Table 92. Sekisui Medical Description and Business Overview
 Table 93. Sekisui Medical Therapeutic Drug Monitoring Product
 Table 94. Sekisui Medical Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 96. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 97. Sekisui Medical Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 98. Sekisui Medical Recent Developments
 Table 99. DAT Diagnostic Corporation Information
 Table 100. DAT Diagnostic Description and Business Overview
 Table 101. DAT Diagnostic Therapeutic Drug Monitoring Product
 Table 102. DAT Diagnostic Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 104. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 105. DAT Diagnostic Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 106. DAT Diagnostic Recent Developments
 Table 107. Chromai Corporation Information
 Table 108. Chromai Description and Business Overview
 Table 109. Chromai Therapeutic Drug Monitoring Product
 Table 110. Chromai Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Product in 2024
 Table 112. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Application in 2024
 Table 113. Chromai Revenue Proportion of Therapeutic Drug Monitoring by Geographic Area in 2024
 Table 114. Chromai Recent Developments
 Table 115. North America Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 116. North America Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 117. North America Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 118. North America Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Asia-Pacific Therapeutic Drug Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 120. Asia-Pacific Therapeutic Drug Monitoring Revenue by Region (2026-2031) & (US$ Million)
 Table 121. Asia-Pacific Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 122. Asia-Pacific Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 123. Europe Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 124. Europe Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 125. Europe Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 126. Europe Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Latin America Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 128. Latin America Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 129. Latin America Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 130. Latin America Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 131. Middle East and Africa Therapeutic Drug Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 132. Middle East and Africa Therapeutic Drug Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 133. Middle East and Africa Therapeutic Drug Monitoring Revenue by Type (2020-2025) & (US$ Million)
 Table 134. Middle East and Africa Therapeutic Drug Monitoring Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Therapeutic Drug Monitoring Key Raw Materials, Industry Status and Trend
 Table 136. Therapeutic Drug Monitoring Key Raw Materials and Upstream Suppliers
 Table 137. Therapeutic Drug Monitoring Clients Status and Trend
 Table 138. Therapeutic Drug Monitoring Typical Clients
 Table 139. Therapeutic Drug Monitoring Distributors
 Table 140. Therapeutic Drug Monitoring Market Trends
 Table 141. Therapeutic Drug Monitoring Market Drivers
 Table 142. Therapeutic Drug Monitoring Market Challenges
 Table 143. Therapeutic Drug Monitoring Market Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Therapeutic Drug Monitoring Product Picture
 Figure 2. Global Therapeutic Drug Monitoring Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Therapeutic Drug Monitoring Revenue Market Share by Type in 2024 & 2031
 Figure 4. Blood Test Product Picture
 Figure 5. Urine Test Product Picture
 Figure 6. Saliva Test Product Picture
 Figure 7. Global Therapeutic Drug Monitoring Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Therapeutic Drug Monitoring Revenue Market Share by Application in 2024 & 2031
 Figure 9. Hospital Labs
 Figure 10. Independent Clinical Laboratories
 Figure 11. Others
 Figure 12. Therapeutic Drug Monitoring Report Years Considered
 Figure 13. Global Therapeutic Drug Monitoring Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Therapeutic Drug Monitoring Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Therapeutic Drug Monitoring Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global Therapeutic Drug Monitoring Revenue Market Share by Region (2020-2031)
 Figure 17. Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. Blood Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Urine Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Saliva Test of Therapeutic Drug Monitoring Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Therapeutic Drug Monitoring Revenue Share by Company (2024)
 Figure 23. Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Blood Test Revenue Proportion by Company in 2024
 Figure 25. Urine Test Revenue Proportion by Company in 2024
 Figure 26. Saliva Test Revenue Proportion by Company in 2024
 Figure 27. North America Therapeutic Drug Monitoring Revenue 2020-2031 (US$ Million)
 Figure 28. North America Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
 Figure 29. North America Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
 Figure 30. Asia-Pacific Therapeutic Drug Monitoring Revenue 2020-2031 (US$ Million)
 Figure 31. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Region (2020-2031)
 Figure 32. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
 Figure 33. Asia-Pacific Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
 Figure 34. Europe Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Europe Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
 Figure 36. Europe Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
 Figure 37. Europe Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
 Figure 38. Latin America Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Latin America Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
 Figure 40. Latin America Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
 Figure 41. Latin America Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
 Figure 42. Middle East and Africa Therapeutic Drug Monitoring Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Country (2020-2031)
 Figure 44. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Type (2020-2025)
 Figure 45. Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Application (2020-2025)
 Figure 46. Therapeutic Drug Monitoring Supply Chain (Upstream and Downstream Market)
 Figure 47. Global Production Market Share of Therapeutic Drug Monitoring Raw Materials by Region in 2024
 Figure 48. Therapeutic Drug Monitoring Distribution Channels
 Figure 49. Global Therapeutic Drug Monitoring Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 50. Global Therapeutic Drug Monitoring Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart